Takeda Pharmaceutical Co Ltd Reports Quarterly Financial Results

Takeda Pharmaceutical Co Ltd has released its quarterly financial results, showing a decline in sales of 8.39% compared to the same period last year.

• Sales decline: 8.39%
• Period: Same as previous year

The company’s earnings per share (EPS) decreased to 79.40 JPY per share, down from 60.71 JPY per share in the previous year.

• Earnings per share (EPS):
  • Current year: 79.40 JPY per share
  • Previous year: 60.71 JPY per share

The company’s stock price has been relatively stable, with a recent dip below its 200-day moving average.

• Stock price movement:
  • Recent dip below 200-day moving average
  • No significant fluctuations reported

Despite the decline in sales and EPS, the company’s long-term prospects remain strong, driven by its focus on research and development in oncology, gastrointestinal, and central nervous system diseases.

• Key drivers:
  • Research and development in oncology
  • Research and development in gastrointestinal diseases
  • Research and development in central nervous system diseases